Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action
Joel E. Schlosburg, Scott T. O’Neal, Daniel H. Conrad, et al.
Psychopharmacology (2011) Vol. 216, Iss. 3, pp. 323-331
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment
Paola Facheris, Jane Jeffery, Ester Del Duca, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 5, pp. 448-474
Open Access | Times Cited: 105
TRP Channel Cannabinoid Receptors in Skin Sensation, Homeostasis, and Inflammation
Michael J. Caterina
ACS Chemical Neuroscience (2014) Vol. 5, Iss. 11, pp. 1107-1116
Open Access | Times Cited: 110
Cannabinoids for the treatment of chronic pruritus: A review
Christina Avila, Susan Massick, Benjamin H. Kaffenberger, et al.
Journal of the American Academy of Dermatology (2020) Vol. 82, Iss. 5, pp. 1205-1212
Closed Access | Times Cited: 85
A Review of Cannabis in Chronic Kidney Disease Symptom Management
Cláudia Ho, Dan Martinusen, Christine Lo
Canadian Journal of Kidney Health and Disease (2019) Vol. 6
Open Access | Times Cited: 43
Cannabis and the skin
Kimberly Shao, Campbell L. Stewart, Jane M. Grant‐Kels
Clinics in Dermatology (2021) Vol. 39, Iss. 5, pp. 784-795
Closed Access | Times Cited: 39
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence
Ming Jiang, Mirjam Huizenga, Jonah L. Wirt, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Evaluation of sex differences in cannabinoid dependence
Julie A. Marusich, Timothy W. Lefever, Kateland R. Antonazzo, et al.
Drug and Alcohol Dependence (2014) Vol. 137, pp. 20-28
Open Access | Times Cited: 43
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12
Marijuana and Cannabinoids in ESRD and Earlier Stages of CKD
Joshua L. Rein, Christina Wyatt
American Journal of Kidney Diseases (2017) Vol. 71, Iss. 2, pp. 267-274
Closed Access | Times Cited: 34
Advances in Understanding the Initial Steps of Pruritoceptive Itch: How the Itch Hits the Switch
Shirin Kahremany, Lukas Hofmann, Arie Gruzman, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4883-4883
Open Access | Times Cited: 30
Analysis of Tolerance and Behavioral/Physical Dependence during Chronic CB1Agonist Treatment: Effects of CB1Agonists, Antagonists, and Noncannabinoid Drugs
Rajeev I. Desai, Ganesh A. Thakur, Kiran Vemuri, et al.
Journal of Pharmacology and Experimental Therapeutics (2012) Vol. 344, Iss. 2, pp. 319-328
Open Access | Times Cited: 38
Oleoylethanolamide: A Novel Potential Pharmacological Alternative to Cannabinoid Antagonists for the Control of Appetite
Adele Romano, Roberto Coccurello, Giacomo Giacovazzo, et al.
BioMed Research International (2014) Vol. 2014, pp. 1-10
Open Access | Times Cited: 30
Pharmacological characterization of a rat Nav1.7 loss-of-function model with insensitivity to pain
Lubin Chen, Philip R. Effraim, Jennifer Carrara, et al.
Pain (2020) Vol. 161, Iss. 6, pp. 1350-1360
Closed Access | Times Cited: 24
Biosynthesis and Pharmacology of Phytocannabinoids and Related Chemical Constituents
Brian F. Thomas, Mahmoud A. ElSohly
Elsevier eBooks (2015), pp. 27-41
Closed Access | Times Cited: 25
Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist
K. A. Bilir, G. Anli, Ekin Ozkan, et al.
Clinical and Experimental Dermatology (2018) Vol. 43, Iss. 5, pp. 553-558
Closed Access | Times Cited: 21
Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases
Amber Cintosun, Irene Lara‐Corrales, Elena Pope
Clinical Drug Investigation (2020) Vol. 40, Iss. 4, pp. 293-304
Closed Access | Times Cited: 19
Early onset female pattern hair loss: A case–control study for analyzing clinical features and genetic variants
Jungyoon Ohn, Ho‐Young Son, Da‐Ae Yu, et al.
Journal of Dermatological Science (2022) Vol. 106, Iss. 1, pp. 21-28
Open Access | Times Cited: 11
Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase
Nurcan Calimli Tosun, Özgür Gündüz, Ahmet Ulugöl
Journal of Neural Transmission (2014) Vol. 122, Iss. 3, pp. 363-367
Closed Access | Times Cited: 21
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats
Fiona Wright, R.J. Rodgers
Psychopharmacology (2012) Vol. 226, Iss. 2, pp. 415-431
Closed Access | Times Cited: 18
Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice
Özgür Yeşilyurt, Mutlu Çayırlı, Yusuf Serdar Sakın, et al.
Archives of Dermatological Research (2016) Vol. 308, Iss. 5, pp. 335-345
Closed Access | Times Cited: 14
Descending serotonergic and noradrenergic systems do not regulate the antipruritic effects of cannabinoids
Zeynep Gizem Todurga Seven, Özgür Gündüz, Çetin Hakan Karadağ, et al.
Acta Neuropsychiatrica (2016) Vol. 28, Iss. 6, pp. 321-326
Closed Access | Times Cited: 11
Neuropathic itch treated with oral cannabinoids: A case series
Catherine Besner Morin, Haya S. Raef, Sarina B. Elmariah
JAAD Case Reports (2021) Vol. 17, pp. 38-42
Open Access | Times Cited: 8
Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice
Sherrica Tai, Tamara Vasiljevik, Alexander M. Sherwood, et al.
Drug and Alcohol Dependence (2018) Vol. 192, pp. 285-293
Open Access | Times Cited: 6
Electroacupuncture reduces chronic itch via cannabinoid CB1 receptors in the ventrolateral periaqueductal gray
Wenqiang Ge, Ouyang Zhanmu, Chao Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist
Oyku Zeynep Gercek, Busra Oflaz, Neslihan Oguz, et al.
Basic and Clinical Neuroscience Journal (2020)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top